Dr. Praveen R works at Biocon Bangalore, for the regulation of Medical affairs. The key responsibilities of his team include strategic execution of medical activities for therapeutic areas and also in reviewing studies or new launch proposals to make funding decisions and product pipeline expansions. The availability of novel therapies is more important and active towards the management of diabetes.
In this regard, Tregopil drug is an emerging molecule for effective management. This exclusive commentary briefs about the availability of novel insulin therapies towards active management of diabetes. Also Dr. Praveen shares his views about IDEC 2019.
